文献速递脑血管病

慢性肾脏病与脑出血风险的关联

Association of Chronic Kidney Disease With Risk of Intracerebral Hemorrhage.
PubMed 文献 · JAMA Neurol · 2022-01-01

该三阶段研究结合观察性与遗传学分析,在美国ERICH多中心病例对照研究中发现慢性肾脏病(CKD)与脑出血(ICH)风险独立相关(OR 1.95),在英国生物银行(UKB)中重复验证(OR 1.28),孟德尔随机化分析提示遗传决定的CKD与ICH风险相关(OR 1.56),作者认为该关联为因果性,但需进一步研究介导此关联的具体生物学通路。

要点

  • ERICH研究中CKD与ICH风险独立相关(OR 1.95,95%CI 1.35-2.89,P<.001)。
  • UKB重复验证该关联(OR 1.28,95%CI 1.01-1.62,P=.04)。
  • 孟德尔随机化提示遗传决定的CKD与ICH风险相关(OR 1.56,95%CI 1.13-2.16,P=.007)。

核心结论

  • 在两个特征和研究设计不同的大型观察性研究参与者中,CKD一致地与较高的ICH风险相关。
  • 孟德尔随机化分析提示该关联为因果性。
  • 需进一步研究确定介导此关联的具体生物学通路。

研究设计与样本

  • 三阶段研究,结合观察性与遗传学分析。
  • 第一阶段在美国ERICH多中心病例对照研究中检验CKD与ICH风险的关联,纳入ERICH中所有有CKD数据的参与者;ERICH于2010年8月1日至2017年8月1日开展,观察参与者1年。
  • 第二阶段在英国生物银行(UKB)重复该分析,纳入UKB所有参与者;UKB于2006年至2010年入组参与者,并将继续观察30年。
  • 第三阶段在UKB中使用27个CKD相关遗传变异进行孟德尔随机化分析以检验遗传关联。
  • 数据分析于2019年11月11日至2022年5月10日进行。

主要发现

  • ERICH研究中,共评估2914例ICH参与者与2954例有CKD数据的对照(平均[SD]年龄61.6[14.0]岁;女性2433例[41.5%];男性3435例[58.5%]);CKD与较高的ICH风险独立相关(OR 1.95;95%CI 1.35-2.89;P<.001)。
  • 该关联未受种族和族裔修饰。
  • UKB重复验证纳入1341例ICH参与者与501195例对照(平均[SD]年龄56.5[8.1]岁;女性273402例[54.4%];男性229134例[45.6%]),确认该关联(OR 1.28;95%CI 1.01-1.62;P=.04)。
  • 孟德尔随机化分析表明遗传决定的CKD与ICH风险相关(OR 1.56;95%CI 1.13-2.16;P=.007)。

关键数值与推荐

  • ERICH研究中CKD与ICH风险的OR为1.95(95%CI 1.35-2.89;P<.001)。
  • UKB中CKD与ICH风险的OR为1.28(95%CI 1.01-1.62;P=.04)。
  • 孟德尔随机化分析中遗传决定的CKD与ICH风险的OR为1.56(95%CI 1.13-2.16;P=.007)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究确定介导该关联的具体生物学通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The evidence linking chronic kidney disease (CKD) to spontaneous intracerebral hemorrhage (ICH) is inconclusive owing to possible confounding by comorbidities that frequently coexist in patients with these 2 diseases. OBJECTIVE: To determine whether there is an association between CKD and ICH risk. DESIGN, SETTING, AND PARTICIPANTS: A 3-stage study that combined observational and genetic analyses was conducted. First, the association between CKD and ICH risk was tested in the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study, a multicenter case-control study in the US. All participants with available data on CKD from ERICH were included. Second, this analysis was replicated in the UK Biobank (UKB), an ongoing population study in the UK. All participants in the UKB were included in this study. Third, mendelian randomization analyses were implemented in the UKB using 27 CKD-related genetic variants to test for genetic associations. ERICH was conducted from August 1, 2010, to August 1, 2017, and observed participants for 1 year. The UKB enrolled participants between 2006 and 2010 and will continue to observe them for 30 years. Data analysis was performed from November 11, 2019, to May 10, 2022. EXPOSURES: CKD stages 1 to 5. MAIN OUTCOMES AND MEASURES: The outcome of interest was ICH, ascertained in ERICH via expert review of neuroimages and in the UKB via a combination of self-reported data and International Statistical Classification of Diseases, Tenth Revision, codes. RESULTS: In the ERICH study, a total of 2914 participants with ICH and 2954 controls who had available data on CKD were evaluated (mean [SD] age, 61.6 [14.0] years; 2433 female participants [41.5%]; 3435 male participants [58.5%]); CKD was found to be independently associated with higher risk of ICH (odds ratio [OR], 1.95; 95% CI, 1.35-2.89; P < .001). This association was not modified by race and ethnicity. Replication in the UKB with 1341 participants with ICH and 501 195 controls (mean [SD] age, 56.5 [8.1] years; 273 402 female participants [54.4%]; 229 134 male participants [45.6%]) confirmed this association (OR, 1.28; 95% CI, 1.01-1.62; P = .04). Mendelian randomization analyses indicated that genetically determined CKD was associated with ICH risk (OR, 1.56; 95% CI, 1.13-2.16; P = .007). CONCLUSIONS AND RELEVANCE: In this 3-stage study that combined observational and genetic analyses among study participants enrolled in 2 large observational studies with different characteristics and study designs, CKD was consistently associated with higher risk of ICH. Mendelian randomization analyses suggest that this association was causal. Further studies are needed to identify the specific biological pathways that mediate this association.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Vanent KN, Leasure AC, Acosta JN, et al. Association of Chronic Kidney Disease With Risk of Intracerebral Hemorrhage. JAMA Neurol. 2022. PMID: 35969388. doi:10.1001/jamaneurol.2022.2299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。